Skip to main content
Applications due for PharmAlliance Investment Strategy Fund (Round 5) - FAO UNC Eshelman School of Pharmacy

Loading Events

« All Events

  • This event has passed.

Applications due for PharmAlliance Investment Strategy Fund (Round 5)

July 31, 2019 @ 8:00 am - 5:00 pm

PharmAlliance Investment Strategy (Round 5)

Proposal Application Guidelines

Preamble: Each School recognizes that strategic investment is required to accelerate collaborations and achieve PharmAlliance objectives and priorities. Funding is intended to support the planning and development of education, practice/professional engagement, or research projects/programs consistent with the PharmAlliance mission.

Travel and Planning Grants: Funds (up to US$10,000 to support travel, lodging, planning costs) are available at any time to facilitate the development of collaborative proposals for future extramural funding. Applications (≤2 pages total; duration ≤6 months) can be sent via email directly to Applications should address each of the questions listed below under “Proposal Review Criteria”. PharmAlliance Leadership would like to encourage the use of Travel and Planning Grants to support student, graduate student, and postdoctoral researcher exchange at other PharmAlliance institutions for the purposes of commencing a collaborative project to further the PharmAlliance mission. Project costs cannot be requested within travel funds unless they are part of student/graduate student/postdoctoral placement. Applications directly from students, graduate students and postdoctoral researchers are encouraged, but require approval from their direct supervisor(s).

Students, graduate students and postdoctoral researchers can be on teams applying for Tier A and B grants, but those applications must be led by their faculty group leader.

Funding Tiers (Funds for either Tier require strong justification and evidence of potential high impact):

Tier A (up to US$50,000) – To support projects/studies for development of more advanced collaborative programs, projects, grants, or proposals beyond the initial planning stages.

Tier B (up to US$100,000) – To support unique collaborative opportunities consistent with the mission of the PharmAlliance that require the generation of additional preliminary data or evidence of collaboration between the Alliance faculty or programs prior to the submission of an extramural grant or program proposal.

Note: Travel costs, including student/graduate student/postdoctoral exchange, can be included in Tier A or B applications. However, the maximum request for funding remains the same, and the maximum travel component is capped at US$10,000.

ROUND 5: In this round, applications in all areas consistent with the mission of the PharmAlliance are welcome. Priority will be given to applications where faculty are available to participate in the next PharmAlliance Research Symposium (PARS 2020) in Chapel Hill (March 30-April 3, 2020). Applications in the following areas will be especially encouraged:

i) Global grand challenges including mental health/well-being, opioids, neuroscience, medication safety/falsified medicines, malaria/infectious diseases.

ii) Educational innovation or research that has the potential to transform the pharmacy curriculum at each PharmAlliance institution.

iii) Applications that address collaborative projects in previous priority areas (antimicrobial resistance, rare/neglected diseases, drug delivery/biopharmaceutics/nanomedicines).

iv) Applications that meet the Proposal Review Criteria and include a student/graduate student or early career researcher exchange (includes Travel and Planning Grant applications – see attached guidelines).

General Instructions:

• At least two institutions must be represented in an application; limit of one PI & one Co-PI proposal per faculty member per round. Institutional representatives must have a primary appointment within the School of Pharmacy unless otherwise approved by the Dean/Director of Pharmacy at that School.

• Budgets should be broken down by institution and developed according to institutional policies. (Note: early discussions should occur at each School prior to proposal development because each School needs to work within their own institution’s financial budgets, regulations and associated procedures, and financial priorities)

• Travel requests in the application may not exceed US$10K and must be for the project (e.g., not conference travel).

• Submit proposals online using the proposal web form at the PharmAlliance website: by Wednesday, July 31, 2019 (in your local time zone).

Proposal Review Criteria (proposals should address each question):

How will funding accelerate the collaborative mission of PharmAlliance and uniquely add value to the development and evolution of PharmAlliance?

How does the idea have the potential to radically, NOT incrementally, improve global health or healthcare, education or research?

How will funding enhance the competitiveness of the team in seeking ongoing (external) funding support? What specific funding schemes are anticipated to provide project sustainability?

Proposal Review Process: Associate Deans/Directors for education/practice/research from UNC, Monash, and UCL will review all proposals and provide recommendations to the Deans/Director for final decision (~6-8 week review timeline). Funds will only be allocated to proposals that explicitly accelerate the collaborative mission of the PharmAlliance and are not an alternative source of faculty funding. No written feedback will be provided regarding the review process/outcomes.

Reporting: The PIs of successful proposals will submit a progress report (halfway) and a final report (~one month after the conclusion of the agreed work program). The progress report (1 page) will include an assessment of accomplishments, issues and progress against milestones. The final report (2 pages) will describe the outcomes, impact, next steps to secure external funding, and a statement of the funds expended at each School.

Acknowledgement: Successful proposals must acknowledge PharmAlliance funding in manuscripts, posters, abstracts, etc.:

“This study was financially supported, in part, by the PharmAlliance, a partnership between the Schools of Pharmacy at The University of North Carolina at Chapel Hill, University College London, and Monash University”.

Student, Graduate Student and Early Career Scholar Exchange Program


The PharmAlliance partners each recognize the importance of student and postdoctoral exchange to drive the projects of the PharmAlliance and to add value to the education of our students and early career scholars. The PharmAlliance wishes to encourage and support the exchange of PhD candidates, Master’s research students and Early Career Scholars (ECSs).


The exchange program will enable students and junior faculty staff to: collaborate, undertake data collection, learn new techniques, pursue research in specific data sets or databases, conduct surveys and interviews, and utilize specialty equipment or resources not available at their own University.

General Principles of Exchange across all PharmAlliance partners

Cost of Project

There is no financial support mechanism at any partner institution to fund the cost of the project conducted by one of their students at another University. Therefore, it is expected that the cost of all reagents, consumables, equipment access, etc., will be the responsibility of the host group unless otherwise negotiated.

Cost of Travel and Accommodation

It is expected that students and ECSs will investigate all internal and external travel schemes available to them to help support the costs of the exchange visit, but they may request funds from the PharmAlliance Project Support Scheme up to the value of a Travel and Planning Grant (US$10,000). Costs will be the responsibility of the PharmAlliance partner sending the student or ECS out. A justification for these funds should be made in the application form. Where PharmAlliance funding is received, it is the expectation that the recipient acknowledges this contribution on publications, posters, abstracts, etc.

Early Career Scholars (ECSs)

An ECS is defined as a scholar up to 10 years post PhD or PharmD, with the exception of scholars with a career interruption such as parental leave.

Enrolment Status of Student or Graduate Students on Exchange

Visiting students are not required to enroll at the institution they visit. They will be classified as “visitors”.

All students will continue to be enrolled at their home institution while on exchange.

Interested students should work with their supervisor(s) to determine the suitability of this program to their circumstances based on their progression and current status in their training program, and the alignment of their dissertation project with the research interests of the host group at the partner institution. Students must comply with all local requirements and restrictions as they relate to their enrollment status.


As students will not enroll at the institution they visit, no tuition or student fees will be charged.


The duration of the exchange program will be limited by the regulations at the outgoing and the incoming institution. Students may also be restricted by the visa they are issued to enter the country of their host. It is the responsibility of the student to determine these limits before the exchange is approved.

Further information on the research expertise at each School is available via the links below. The contacts for this program at each institution are also listed.


Ahad Rahim (


David Steeb (


Tom Keegan (


July 31, 2019
8:00 am - 5:00 pm